Hamid, O., Lewis, K., Weise, A., McKean, M., Papadopoulos, K.P., Crown, J., Kim, T.M., Lakhani, N.J., Kaczmar, J., Kudchadkar, R., Spira, A., Rabinowits, G., Kim, K., Carvajal, R., Williamson, S., Ioffe, E., Chen, S., Mani, J., Jankovic, V., Brennan, L., Kroog, G., Sims, T., Lowy, I. and Gullo, G. 2023. Phase 1 study of fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab in advanced melanoma: Expansion cohort analysis. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s179. DOI:https://doi.org/10.25251/skin.7.supp.179.